期刊文献+

IL-24 cDNA转染人喉癌细胞系的建立及其表达的研究

Establishment of Human Laryngeal Cancer Cell Line Transfected with Human IL-24 cDNA and Its Expression
下载PDF
导出
摘要 目的建立转染人白细胞介素-24(hIL-24)基因的喉癌细胞株,并研究hIL-24的表达情况。方法将携带人白细胞介素-24的质粒pcDNA3.1(+)-hIL-24转导入人喉表皮样癌细胞Hep-2中,G418筛选阳性克隆,RT-PCR、Western blot和ELISA法对hIL-24的表达进行检测。结果IL-24基因成功地转导入Hep-2细胞中并能高效表达。RT-PCR电泳结果显示hIL-24基因在mRNA水平有表达;ELISA法测得106个转染阳性细胞24 h内培养上清液中hIL-24的含量为162.8±15.4 pg/mL,空载体转染及未转染的细胞未检测到hIL-24。结论hIL-24基因成功转染人喉癌细胞系Hep-2细胞且能持续大量表达。 Objective To establish human laryngeal cancer cell line transfected with human IL- 24 cDNA and demonstrate its expression in laryngeal cancer cell. Methods The recombinant expression plasmid pcDNA3. 1( + ) -hIL- 24 was transfected into human laryngeal cancer cell line Hep- 2 cells and the positive clone was screened by G418.Then the expression of hIL-24 in Hep- 2 cells was tested by RT-PCR and Western blot assay; the secretion of hIL - 24 in medium was detected by ELISA. Results Human IL- 24 cDNA was successfully integrated into Hep - 2 cells and overexpressed. The result of RT - PCR showed that IL - 24 mRNA was detect- ed, The concentration of hIL - 24 in the supematants of the 106 transfected Hep - 2 cell cultures in 24 hours as detected by ELISA was( 162.8 ± 15.4)pg/mL, no hIL- 24 expression was detected in control group, Conclusion Human IL - 24 cDNA was successfully integrated into Hep - 2 cells and could be expressed with high efficiencv.
出处 《南华大学学报(医学版)》 2007年第3期389-391,400,共4页 Journal of Nanhua University(Medical Edition)
关键词 人白细胞介素-24 转染 喉癌细胞 表达 human interleukin - 24 transfection laryngeal cancer cell expression
  • 相关文献

参考文献11

  • 1Jiang H, Lin JJ, Su ZZ, et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda - 7, modulated during human melanoma differentiation, growth and progression[J]. Oncogene, 1995, 11 (12):2477 - 2486.
  • 2Inoue S, Shanker M, Miyahara R, et al. MDA- 7/IL - 24 - based cancer gene therapy: translation from the laboratory to the clinic [ J ]. Curr Gene Ther, 2006, 6(1) :73 - 91.
  • 3Fisher PB. Is mda - 7/IL - 24 a "magic bullet" for cancer [J]. Cancer Res, 2005, 65 (22) :10128- 10138.
  • 4金冬雁.黎孟枫译.分子克隆实验指南.第2版[M].北京:科学出版社,2002.16—34.
  • 5Lichtor T, Glick RP, Tadock K, et al. Application of intedeukin - 2- secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors[J].Cancer Gene Ther, 2002,9(5) :464 - 469.
  • 6Wu CM, Li XY, Huang TH. Anti - tumor effect of pEgr- IFNgamma gene - radiotherapy in B16 melanoma -bearing mice[J]. World J Gastroenterol, 2004, 10(20) :3011 - 3015.
  • 7Pastorakova A, Hlubinova K, Bodo J, et al. Tmnor targetecl gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivo[ J]. Neoplasma,2005,52(4) :344 - 351.
  • 8Park KH, Kim G, Jang SH, et al. Gene therapy with GM-CSF, intedeukin- 4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer[J]. Anticancer Res, 2003,23(2B): 1559- 1564.
  • 9Caudell EG, Mumm JB, Poindexter N, et al. The protein product of the tumor suppressor gene, melanoma differentiation- associated gene 7, exhibits immunostimulatory activity and is designated IL - 24 [ J ]. J Immunol, 2002,168(12) :6041 - 6046.
  • 10Yacoub A, Mitchell C, Lister A, et al. Melanoma differentiation- associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo[J]. Clin Cancer Res,2003, 9(9) :3272- 3281.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部